Treatment of lithium-induced tremor with nadolol.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D006801:Humans; D008094:Lithium / Q000009:adverse effects* / Q000097:blood; D008875:Middle Aged; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use*; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol; D008094:Lithium